Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV7 versus 23PPV in hospitalized elderly adults
ACTRN12607000387426Phase 4Completed
- Sponsor
- Professor C Raina MacIntyre
- Start
- May 2005
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of pneumococcal 7-valent conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease (2 arms), sponsored by Professor C Raina MacIntyre. Primary endpoint: Immunogenicity. Started May 2005; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on ACTRN12607000387426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000387426.